ABL’s fill and finish drug manufacturing capabilities meet U.S. FDA and European GMP requirements for a wide variety of live/vectored products at pilot and clinical scales and commercial-ready. Our in Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
Congrats to partner Genomics Medicine Ireland on $40m series A - building population genomics R&D in Ireland! Read More
Sofregen Medical Inc., the company pioneering silk-based medical technologies to address soft tissue defects, today announced a $6.2 million Series A financing from Polaris Partners and other founding investors who previously... Read More
Evelo Biosciences, the pioneer of Oncobiotic™ Therapies, microbiome-based therapeutics for cancer, is dedicating $1M to award up to 10 grants for joint studies exploring the human microbiome and cancer. Evelo will participate... Read More
Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies that improves the lives of people living with rare genetic diseases, today announced the launch of Imara, Inc. Read More
BioSciKin and its related investment firms are looking for life science companies to fund and form strategic collaboration. DEADLINE FOR REGIESTRATION IS MARCH 15TH Read More
A startup with roots at MIT and Harvard that has been reinventing diabetes care in India brings the fight against chronic diseases to the U.S. with operations in Boston, MA. Read More